Cargando…
CTSB promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway
BACKGROUND: Acute kidney injury is a common and severe complication of sepsis. Sepsis -induced acute kidney injury(S-AKI) is an independent risk factor for mortality among sepsis patients. However, the mechanisms of S-AKI are complex and poorly understand. Therefore, exploring the underlying mechani...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880165/ https://www.ncbi.nlm.nih.gov/pubmed/36713420 http://dx.doi.org/10.3389/fimmu.2022.1053754 |
_version_ | 1784878846298816512 |
---|---|
author | Wang, Yuting Xi, Wenjie Zhang, Xinyi Bi, Xinwen Liu, Boyang Zheng, Xiaoming Chi, Xinjin |
author_facet | Wang, Yuting Xi, Wenjie Zhang, Xinyi Bi, Xinwen Liu, Boyang Zheng, Xiaoming Chi, Xinjin |
author_sort | Wang, Yuting |
collection | PubMed |
description | BACKGROUND: Acute kidney injury is a common and severe complication of sepsis. Sepsis -induced acute kidney injury(S-AKI) is an independent risk factor for mortality among sepsis patients. However, the mechanisms of S-AKI are complex and poorly understand. Therefore, exploring the underlying mechanisms of S-AKI may lead to the development of therapeutic targets. METHOD: A model of S-AKI was established in male C57BL/6 mice using cecal ligation and puncture (CLP). The data-independent acquisition (DIA)-mass spectrometry-based proteomics was used to explore the protein expression changes and analyze the key proteomics profile in control and CLP group. The methodology was also used to identify the key proteins and pathways. S-AKI in vitro was established by treating the HK-2 cells with lipopolysaccharide (LPS). Subsequently, the effect and mechanism of Cathepsin B (CTSB) in inducing apoptosis in HK-2 cells were observed and verified. RESULTS: The renal injury scores, serum creatinine, blood urea nitrogen, and kidney injury molecule 1 were higher in septic mice than in non-septic mice. The proteomic analysis identified a total of 449 differentially expressed proteins (DEPs). GO and KEGG analysis showed that DEPs were mostly enriched in lysosomal-related cell structures and pathways. CTSB and MAPK were identified as key proteins in S-AKI. Electron microscopy observed enlarged lysosomes, swelled and ruptured mitochondria, and cytoplasmic vacuolization in CLP group. TUNEL staining and CTSB activity test showed that the apoptosis and CTSB activity were higher in CLP group than in control group. In HK-2 cell injury model, the CTSB activity and mRNA expression were increased in LPS-treated cells. Acridine orange staining showed that LPS caused lysosomal membrane permeabilization (LMP). CA074 as an inhibitor of CTSB could effectively inhibit CTSB activity. CCK8 and Annexin V/PI staining results indicated that CA074 reversed LPS-induced apoptosis of HK-2 cells. The JC-1 and western blot results showed that LPS inhibited mitochondrial membrane potential and activated mitochondrial apoptosis pathway, which could be reversed by CA074. CONCLUSIONS: LMP and CTSB contribute to pathogenesis of S-AKI. LPS treatment induced HK-2 cell injury by activating mitochondrial apoptosis pathway. Inhibition of CTSB might be a new therapeutic strategy to alleviate sepsis-induced acute kidney injury. |
format | Online Article Text |
id | pubmed-9880165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98801652023-01-28 CTSB promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway Wang, Yuting Xi, Wenjie Zhang, Xinyi Bi, Xinwen Liu, Boyang Zheng, Xiaoming Chi, Xinjin Front Immunol Immunology BACKGROUND: Acute kidney injury is a common and severe complication of sepsis. Sepsis -induced acute kidney injury(S-AKI) is an independent risk factor for mortality among sepsis patients. However, the mechanisms of S-AKI are complex and poorly understand. Therefore, exploring the underlying mechanisms of S-AKI may lead to the development of therapeutic targets. METHOD: A model of S-AKI was established in male C57BL/6 mice using cecal ligation and puncture (CLP). The data-independent acquisition (DIA)-mass spectrometry-based proteomics was used to explore the protein expression changes and analyze the key proteomics profile in control and CLP group. The methodology was also used to identify the key proteins and pathways. S-AKI in vitro was established by treating the HK-2 cells with lipopolysaccharide (LPS). Subsequently, the effect and mechanism of Cathepsin B (CTSB) in inducing apoptosis in HK-2 cells were observed and verified. RESULTS: The renal injury scores, serum creatinine, blood urea nitrogen, and kidney injury molecule 1 were higher in septic mice than in non-septic mice. The proteomic analysis identified a total of 449 differentially expressed proteins (DEPs). GO and KEGG analysis showed that DEPs were mostly enriched in lysosomal-related cell structures and pathways. CTSB and MAPK were identified as key proteins in S-AKI. Electron microscopy observed enlarged lysosomes, swelled and ruptured mitochondria, and cytoplasmic vacuolization in CLP group. TUNEL staining and CTSB activity test showed that the apoptosis and CTSB activity were higher in CLP group than in control group. In HK-2 cell injury model, the CTSB activity and mRNA expression were increased in LPS-treated cells. Acridine orange staining showed that LPS caused lysosomal membrane permeabilization (LMP). CA074 as an inhibitor of CTSB could effectively inhibit CTSB activity. CCK8 and Annexin V/PI staining results indicated that CA074 reversed LPS-induced apoptosis of HK-2 cells. The JC-1 and western blot results showed that LPS inhibited mitochondrial membrane potential and activated mitochondrial apoptosis pathway, which could be reversed by CA074. CONCLUSIONS: LMP and CTSB contribute to pathogenesis of S-AKI. LPS treatment induced HK-2 cell injury by activating mitochondrial apoptosis pathway. Inhibition of CTSB might be a new therapeutic strategy to alleviate sepsis-induced acute kidney injury. Frontiers Media S.A. 2023-01-13 /pmc/articles/PMC9880165/ /pubmed/36713420 http://dx.doi.org/10.3389/fimmu.2022.1053754 Text en Copyright © 2023 Wang, Xi, Zhang, Bi, Liu, Zheng and Chi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Wang, Yuting Xi, Wenjie Zhang, Xinyi Bi, Xinwen Liu, Boyang Zheng, Xiaoming Chi, Xinjin CTSB promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway |
title | CTSB promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway |
title_full | CTSB promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway |
title_fullStr | CTSB promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway |
title_full_unstemmed | CTSB promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway |
title_short | CTSB promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway |
title_sort | ctsb promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880165/ https://www.ncbi.nlm.nih.gov/pubmed/36713420 http://dx.doi.org/10.3389/fimmu.2022.1053754 |
work_keys_str_mv | AT wangyuting ctsbpromotessepsisinducedacutekidneyinjurythroughactivatingmitochondrialapoptosispathway AT xiwenjie ctsbpromotessepsisinducedacutekidneyinjurythroughactivatingmitochondrialapoptosispathway AT zhangxinyi ctsbpromotessepsisinducedacutekidneyinjurythroughactivatingmitochondrialapoptosispathway AT bixinwen ctsbpromotessepsisinducedacutekidneyinjurythroughactivatingmitochondrialapoptosispathway AT liuboyang ctsbpromotessepsisinducedacutekidneyinjurythroughactivatingmitochondrialapoptosispathway AT zhengxiaoming ctsbpromotessepsisinducedacutekidneyinjurythroughactivatingmitochondrialapoptosispathway AT chixinjin ctsbpromotessepsisinducedacutekidneyinjurythroughactivatingmitochondrialapoptosispathway |